Your browser doesn't support javascript.
loading
Impact of the COVID-19 pandemic on new diagnoses of type 2 diabetes in England.
Barron, Emma; Khunti, Kamlesh; Wright, Alison K; Ashcroft, Darren M; Carr, Matthew J; Rutter, Martin K; Valabhji, Jonathan.
Afiliación
  • Barron E; NHS England, London, UK.
  • Khunti K; Diabetes Research Centre, Leicester Diabetes Centre, University of Leicester, Leicester, UK.
  • Wright AK; Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Ashcroft DM; Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Carr MJ; NIHR Greater Manchester Patient Safety Research Collaboration (PSRC), University of Manchester, Manchester, UK.
  • Rutter MK; Manchester Academic Health Science Centre, Manchester, UK.
  • Valabhji J; Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Diabetes Obes Metab ; 25(11): 3424-3429, 2023 11.
Article en En | MEDLINE | ID: mdl-37489091

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido